Strategic Opportunities Committee


President-Elect and Chair
Daniel E. Sabath, MD, PhD
University of Washington Medical Center

Molecular pathology exists within a rapidly changing environment. The Strategic Opportunities Committee asseses the opportunities and challenges in the molecular pathology profession and other environments external to the organization that affect AMP interests.

The Strategic Opportunities Committee carries out the activities listed below and provides relevant reports and recommendations to the Board of Directors:

  • Assessing trends and activities in the broad environment external to AMP, i.e., "Horizon Scanning";
  • Identifying and assessing external threats that could prevent AMP from attaining its goals;
  • Identifying and assessing external opportunities that can help AMP attain its goals;
  • Identifying organizations for potential relationships that can help AMP attain its goals.


Committee Members - 2020-2021

If you are interested in serving on the Strategic Opportunities Committee, please see the various roles available and the responsibilities of each role by clicking here.

Chair (2021)
Daniel E. Sabath, MD, PhD
University of Washington Medical Center

Board Member (2020-2021)
Lawrence J. Jennings, MD, PhD
Northwestern Memorial Hospital

Board Member (2020-2021)
Jordan Laser, MD
North Shore - Long Island Jewish Health System

Member (2018-2021)
Michael Hadjisavas, PhD

Member (2018-2021)
Robert L. Nussbaum, MD

Member (2015-2021)
Ester Stein, BS, MBA

Jonathan Baden, MS
Bristol-Myers Squibb

Jill Hagenkord, MD

Terri E. Ozegovich, BS, MBA

Anthony N. Sireci, MD, MS
Loxo Oncology

Ex Officio Committee Members

Antonia R. Sepulveda, MD, PhD
The George Washington Univeristy Hospital 

Executive Director (Non-Voting)
Mary Steele Williams, MNA, MT(ASCP)SM

Corporate Partners